Steven Cohen’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Steven Cohen’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-168,703	Closed	-$420K	–	1297
2018 Q4	$420K	Hold	168,703	–	–	﹤0.01%	879
2018 Q3	$1.23M	Sell	168,703 -45,297	-21%	-$198K	0.01%	827
2018 Q2	$792K	Buy	214,000 +34,000	+19%	+$157K	﹤0.01%	851
2018 Q1	$693K	Buy	+180,000	New	+$757K	﹤0.01%	841
2016 Q2	–	Sell	-76,659	Closed	-$1.07M	–	914
2016 Q1	$1.07M	Sell	76,659 -642,441	-89%	-$9.42M	0.01%	616
2015 Q4	$14.7M	Sell	719,100 -280,900	-28%	-$4.33M	0.12%	204
2015 Q3	$13.1M	Buy	1,000,000 +35,886	+4%	+$595K	0.1%	255
2015 Q2	$14.8M	Sell	964,114 -67,886	-7%	-$1.3M	0.1%	257
2015 Q1	$20.6M	Buy	1,032,000 +53,520	+5%	+$1.2M	0.14%	199
2014 Q4	$20.6M	Buy	978,480 +491,875	+101%	+$10M	0.14%	209
2014 Q3	$9.06M	Buy	+486,605	New	+$8.81M	0.07%	298

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Steven Cohen's AGTC Position: Q1 2019 in Review

Steven Cohen sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2019, closing a stake of 168,703 shares — an estimated $420K sold.

Steven Cohen first reported a position in AGTC in Q3 2014 and held it in 11 quarters. The position peaked at $20.6M in Q1 2015. 50 funds tracked by Wall St. Rank hold AGTC as of Q1 2019.

Steven Cohen reported no remaining Applied Genetic Technologies Corporation position as of Q1 2019 after selling out during the quarter.
Steven Cohen sold 168,703 Applied Genetic Technologies Corporation shares in Q1 2019, an estimated $420K.
Steven Cohen first reported a position in Applied Genetic Technologies Corporation in Q3 2014 and held it in 11 quarters.
Steven Cohen's Applied Genetic Technologies Corporation position peaked at $20.6M in Q1 2015.
50 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2019.

Based on Point72 Asset Management's 13F filing for Q1 2019, filed 15 May 2019.